RISK: Health, Safety & Environment (1990-2002)


Quality-of-life research is briefly described and said to be in its infancy. However, the authors observe that such studies may, e.g., make it possible to better match patients and therapies. They also predict that, as scientific difficulties are overcome, the pharmaceutical industry will become more active in planning, implementing and evaluating such research.

Repository Citation

Beat Hiltbrunner, Pharmaceutical Risk and the Quality of Life, 2 RISK 19 (1991).